Designing a Nanotech Imaging Agent for MRI/PET
An early and accurate diagnosis of cancer is essential to improve treatment. The next generation of medical imaging technology combines MRI and PET, and new imaging agents are required to optimally exploit the synergy of both modalities.
In this project you will develop a new imaging agent based on our silicon nanoparticle platform and you will be able to work with CSIRO and Australian’s only research dedicated MR-PET scanner at Monash Biomedical Imaging.
You can expect to learn about the synthesis of porous silicon nanoparticles, functionalization with polymers and chelators, radiochemistry (zirconium-89) and the basics of MRI/PET imaging.